Clinical Trials Browser

Phase 4 × Ovarian Neoplasms × pegylated granulocyte colony-stimulating factor × Clear all

NCT03858166 2024-01-05

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

Phase 4 Terminated

Ovarian Neoplasms